[HTML][HTML] Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies

WH Faour, A Choaib, E Issa, FE Choueiry… - Inflammation …, 2022 - Springer
The COVID-19 pandemic created a worldwide debilitating health crisis with the entire
humanity suffering from the deleterious effects associated with the high infectivity and …

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

Y Zhou, B Fu, X Zheng, D Wang, C Zhao… - National Science …, 2020 - academic.oup.com
Pathogenic human coronavirus infections, such as severe acute respiratory syndrome CoV
(SARS-CoV) and Middle East respiratory syndrome CoV (MERS-CoV), cause high morbidity …

[HTML][HTML] Could SARS-CoV-2-induced hyperinflammation magnify the severity of coronavirus disease (CoViD-19) leading to acute respiratory distress syndrome?

ASS Girija, EM Shankar, M Larsson - Frontiers in immunology, 2020 - frontiersin.org
The exaggerated immune response induced in the lower respiratory tract against
coronaviruses (CoVs), including CoViD-19 (2019-nCoV), appears to contribute to the …

Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential …

A Jafarzadeh, P Chauhan, B Saha, S Jafarzadeh… - Life sciences, 2020 - Elsevier
Abstract The COVID-19-, SARS-and MERS-related coronaviruses share many genomic and
structural similarities. However, the SARS-CoV-2 is less pathogenic than SARS-CoV and …

[HTML][HTML] The role of MSC therapy in attenuating the damaging effects of the cytokine storm induced by COVID-19 on the heart and cardiovascular system

GM Ellison-Hughes, L Colley, KA O'Brien… - Frontiers in …, 2020 - frontiersin.org
The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
that causes coronavirus disease 2019 (COVID-19) has led to 47 m infected cases and 1. 2 m …

[PDF][PDF] Acute renal failure in critically ill COVID-19 patients with a focus on the role of renal replacement therapy: a review of what we know so far

A Raza, A Estepa, V Chan, MS Jafar - Cureus, 2020 - cureus.com
Acute renal failure remains a significant concern in all patients with the coronavirus disease
2019 (COVID-19) infection. Management is particularly challenging in critically ill patients …

[HTML][HTML] Clinical characteristics and short-term outcomes of severe patients with COVID-19 in Wuhan, China

X Feng, P Li, L Ma, H Liang, J Lei, W Li, K Wang… - Frontiers in …, 2020 - frontiersin.org
Background: A novel pneumonia (COVID-19) spread rapidly throughout worldwide, in
December, 2019. Most of the deaths have occurred in severe and critical cases, but …

COVID-19—Toward a comprehensive understanding of the disease

MM Kowalik, P Trzonkowski… - Cardiology …, 2020 - journals.viamedica.pl
The evidence on the pathophysiology of the novel coronavirus SARS-CoV-2 infection is
rapidly growing. Understanding why some patients suffering from COVID-19 are getting so …

[HTML][HTML] Pathophysiology of COVID-19-associated acute kidney injury

M Legrand, S Bell, L Forni, M Joannidis… - Nature Reviews …, 2021 - nature.com
Although respiratory failure and hypoxaemia are the main manifestations of COVID-19,
kidney involvement is also common. Available evidence supports a number of potential …

[HTML][HTML] Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study

SM Kamran, ZH Mirza, A Naseem, J Liaqat, I Fazal… - PLoS …, 2021 - journals.plos.org
Background Cytokine release syndrome (CRS) plays a pivotal role in the pathophysiology
and progression of Coronavirus disease-2019 (COVID-19). Therapeutic plasma exchange …